It was established in 2007 by investment bankers Burrill & Co., of San Francisco, and Kuwait Life Sciences Co., the life sciences arm of Kuwait's National Technology Enterprises Co. (NTEC), in order to in-license and market biologic and small-molecule drugs in the Middle East, Africa, Turkey and Caspian Sea region
It was established in 2007 by investment bankers Burrill & Co., of San Francisco, and Kuwait Life Sciences Co., the life sciences arm of Kuwait's National Technology Enterprises Co. (NTEC), in order to in-license and market biologic and small-molecule drugs in the Middle East, Africa, Turkey and Caspian Sea region
By Cormac Sheridan | BioWorld International | Wednesday, May 22, 2013
It was established in 2007 by investment bankers Burrill & Co., of San Francisco, and Kuwait Life Sciences Co., the life sciences arm of Kuwait's National Technology Enterprises Co. (NTEC), in order to in-license and market biologic and small-molecule drugs in the Middle East, Africa, Turkey and Caspian Sea region